SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-295768
Filing Date
2013-07-19
Accepted
2013-07-19 17:01:01
Documents
3
Period of Report
2013-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d570901d8k.htm 8-K 18010
2 EX-10.1 d570901dex101.htm EX-10.1 5042
3 EX-10.2 d570901dex102.htm EX-10.2 5155
  Complete submission text file 0001193125-13-295768.txt   29618
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 13977520
SIC: 2834 Pharmaceutical Preparations